ShadowBuys

USAspending · Contract award

MCK: Department of Justice contract award

MCKESSON CONTRACT - ACCT 677508 - CONTROLLED AND NON-CONTROLLED MEDICATION PURCHASE FOR INMATE USE FOR OPIOID USE DISORDER TREATMENT (MAT THERAPY) - 90F MEDICATIONS/ 1060ADB -- MULTIPLE INVOICES PURCHASED FOR FY26 1-30 JUNE

Follow MCK
First observed
Nov 9, 2026, 10:30 AM EST
Event / period date
Jun 1, 2026
Collected
Nov 9, 2026, 10:30 AM EST

Why this is connected

Legal-name match: MCKESSON CORPORATION is MCKESSON CORP (https://www.sec.gov/Archives/edgar/data/927653/), differing only in punctuation, "the" or suffix spelling (Corp/Corporation).

Reported contract amount

$21,497.33

Source last modified: Jul 20, 2026

Award Amount is total obligations on this award, not a new incremental commitment or contract ceiling.

Source evidence

Read the source excerpt or record
{"internal_id":357403127,"Award ID":"15B10926F00000085","Recipient Name":"MCKESSON CORPORATION","Award Amount":21497.33,"Description":"MCKESSON CONTRACT - ACCT 677508 - CONTROLLED AND NON-CONTROLLED MEDICATION PURCHASE FOR INMATE USE FOR OPIOID USE DISORDER TREATMENT (MAT THERAPY) - 90F MEDICATIONS/ 1060ADB -- MULTIPLE INVOICES PURCHASED FOR FY26 1-30 JUNE","Awarding Agency":"Department of Justice","Start Date":"2026-06-01","Last Modified Date":"2026-07-20 08:27:29","generated_internal_id":"CONT_AWD_15B10926F00000085_1540_36W79720D0001_3600","awarding_agency_id":252,"agency_slug":"department-of-justice"}

Congressional trading in MCK

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.